ST Renfu announced that the company and its former controlling shareholder, Wuhan Contemporary Technology Industry Group Co., Ltd. received an “Administrative Penalty Decision” from the China Securities Regulatory Commission for suspected illegal disclosure of information. According to the “Securities Law”, Renfu Pharmaceutical Group Co., Ltd. was warned and fined 3.5 million yuan for not promptly disclosing non-operating capital occupation from 2021 to March 2022; a warning was given for major omissions and false records in the 2020 annual report of Renfu Pharmaceutical Group Co., Ltd., false records in the 2021 annual report, false records in the 2022 semi-annual report, and major omissions in the 2022 annual report, and a fine of 5 million yuan. A fine of 4 million yuan was imposed on Wuhan Contemporary Technology Industry Group Co., Ltd. for instructing Renfu Pharmaceutical to provide funds from 2021 to March 2022, causing Renfu Pharmaceutical to fail to disclose information in a timely manner.

ST Renfu announced that the company and its former controlling shareholder, Wuhan Contemporary Technology Industry Group Co., Ltd. received an “Administrative Penalty Decision” from the China Securities Regulatory Commission for suspected illegal disclosure of information. According to the “Securities Law”, Renfu Pharmaceutical Group Co., Ltd. was warned and fined 3.5 million yuan for not promptly disclosing non-operating capital occupation from 2021 to March 2022; a warning was given for major omissions and false records in the 2020 annual report of Renfu Pharmaceutical Group Co., Ltd., false records in the 2021 annual report, false records in the 2022 semi-annual report, and major omissions in the 2022 annual report, and a fine of 5 million yuan. A fine of 4 million yuan was imposed on Wuhan Contemporary Technology Industry Group Co., Ltd. for instructing Renfu Pharmaceutical to provide funds from 2021 to March 2022, causing Renfu Pharmaceutical to fail to disclose information in a timely manner.